Clinical Trials Browser

Phase 2 × OTHER × lonafarnib × Clear all

NCT00038597 2018-10-30

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00773474 2016-02-18

Lonafarnib in Metastatic Breast Cancer

Phase 2 Terminated

29 enrolled 11 charts

Breast Neoplasms

NCT00281515 2012-06-29

Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial